Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew page revision 3.5.2 was added on 2026-04-13 and an older revision 3.5.0 was removed on 2026-04-07. These entries reflect metadata about the page version rather than substantive updates to the study details.SummaryDifference0.1%

- Check17 days agoChange DetectedStudy record timeline updated: 2026-04-07 and 2026-04-08 were added, while 2026-04-01 and 2026-03-31 were removed. These are administrative updates and do not alter core trial content such as eligibility, interventions, or outcomes.SummaryDifference0.1%

- Check24 days agoChange DetectedAdministrative updates were made to the Study Record Dates. Two dates were added (2026-04-01 and 2026-03-31) and two were removed (2026-03-25 and 2026-03-24).SummaryDifference0.1%

- Check31 days agoChange DetectedThe page shows new update dates (2026-03-25 and 2026-03-24) and removal of earlier dates (2026-03-18, 2026-03-17), indicating changes to the study record's update history.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Revision: v3.5.0 (dates: 2026-03-17 and 2026-03-18); and deleted/replaced Revision: v3.4.3 (dates: 2026-03-07 and 2026-03-10).SummaryDifference0.1%

- Check46 days agoChange DetectedNew version entries were added: Revision v3.4.3 on 2026-03-10 and 2026-03-07. The previous Revision v3.4.2 was removed on 2026-03-03 and 2026-02-28.SummaryDifference0.1%

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.